Finnish Telestroke Pilot 2007-2009
1 other identifier
observational
109
1 country
1
Brief Summary
Objective is to describe two years experience from The Finnish Telestroke piloting between Helsinki University Central Hospital (HUCH), Department of Neurology, The Hub, and five hospitals, the spokes. The participating hospitals are from Rovaniemi (Lapland), Kemi (North-West of Finland), Lappeenranta, Kuusankoski and Kotka from South-East of Finland. All the participating hospitals have a stroke unit and the thrombolysis treatment and the follow up of the patients are carried in the treating hospital. The aim of the pilot is to provide these hospitals expertise in thrombolysis treatment during off-hours through teleconsultations. The teleconsultations were begun between the participating hospitals 05/2007 after about 1 years preparation period. During the preparation period the staff from participating hospitals were trained with simulation training and lectures held by the local staff and the faculty of the Helsinki University hospital. Telestroke consultation: During two way interactive audio-visual consultation the thrombolysis decision is based on: 1) the consultant going through a check up list of indications and no contraindications to the treatment together with the treating physician and 2) Clinical assessment of NIHSS by the treating physician under guidance of the consultant through the two way video system besides 3) Evaluation of the head CT scan. The data registered is based on documents made at HUCH and the follow up data provided by the chief neurologist of the other hospitals. 109 teleconsultations have been documented over 2 years period. A unique feature of the Finnish pilot is the high percentage of consultations leading to thrombolysis treatment. Another special feature is that the consultant does the teleconsultation work besides other on call duties.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started May 2007
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
May 1, 2007
CompletedFirst Submitted
Initial submission to the registry
June 3, 2010
CompletedFirst Posted
Study publicly available on registry
June 4, 2010
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2010
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2010
CompletedJune 4, 2010
June 1, 2010
3.6 years
June 3, 2010
June 3, 2010
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
The percentage of thrombolysis treatments per consultations
2 years
Secondary Outcomes (1)
Safety (sICH) and Efficacy (mRS at 3 months) compared with on-site thrombolysis
2 years
Study Arms (1)
All bi-directional telestroke consultations
Eligibility Criteria
All teleconsultations on stroke thrombolysis decision between the Hub (HUCH) and the 5 Spokes during 2 years time period.
You may qualify if:
- All stroke patients inside 4.5 hours from the symptom onset considered as thrombolysis candidates by the treating physician of the spoke. In suspected basilar artery thrombosis up to 48 h from symptom onset.
You may not qualify if:
- Symptom onset \> 4.5 h
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Helsinki University Central Hospitallead
- Kuusankoski Regional Hospital Kuusankoski Finlandcollaborator
- Kymenlaakso Central Hospital Kotka Finlandcollaborator
- Tampere University Hospitalcollaborator
- Central Hospital of Lapland Rovaniemi Finlandcollaborator
- South Carelia Central Hospitalcollaborator
- Länsi-Pohja Central Hospital Kemi Finlandcollaborator
Study Sites (1)
Department of neurology, HUCH
Helsinki, Finland
Related Publications (1)
Tatlisumak T, Soinila S, Kaste M. Telestroke networking offers multiple benefits beyond thrombolysis. Cerebrovasc Dis. 2009;27 Suppl 4:21-7. doi: 10.1159/000213055. Epub 2009 Jun 18.
PMID: 19546538BACKGROUND
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Tiina Sairanen, MD, PhD
Department of Neurology, HUCH, Helsinki, Finland
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
Study Record Dates
First Submitted
June 3, 2010
First Posted
June 4, 2010
Study Start
May 1, 2007
Primary Completion
December 1, 2010
Study Completion
December 1, 2010
Last Updated
June 4, 2010
Record last verified: 2010-06